keyword
headspac
ga
chromatographi
mass
spectrometri
threedimension
print
porou
scaffold
summari
backgroundobject
novel
porou
scaffold
poli
lactidecoglycolid
tricalcium
phosphat
plgatcp
develop
threedimension
print
technolog
bone
defect
repair
class
solvent
less
sever
toxic
content
residu
newli
develop
scaffold
rigor
control
translat
clinic
use
studi
headspac
ga
chromatographymass
spectrometr
hsgcm
method
relat
test
protocol
develop
quantit
determin
plgatcp
composit
scaffold
method
matrix
effect
analysi
use
optimis
pretreat
method
scaffold
procedur
test
use
hsgcm
set
accuraci
precis
robust
newli
develop
quantit
method
also
valid
quantif
scaffold
differ
dri
procedur
result
dimethyl
formamid
dmf
optim
solvent
dissolv
scaffold
gcm
proper
sensit
without
matrix
effect
optimis
procedur
determin
scaffold
dissolv
dmf
kept
c
minut
separ
column
detect
mass
spectroscopi
recoveri
experi
correspond
author
journal
orthopaed
translat
gave
recoveri
linear
rang
determin
ppm
linear
correl
coeffici
intraday
interday
precis
determin
within
rel
standard
deviat
passabl
dri
procedur
relat
lyophilis
c
pa
scaffold
day
dri
vacuum
pa
day
conclus
first
quantit
method
establish
test
novel
scaffold
method
valid
good
accuraci
reproduc
met
methodolog
requir
guidelin
document
chines
pharmacopoeia
edit
translat
potenti
articl
quantit
method
determin
residu
novel
scaffold
key
technic
method
translat
clinic
use
method
import
indispens
file
enterpris
standard
porou
scaffold
regist
class
iii
implant
medic
devic
bone
defect
repair
use
guarante
safeti
scaffold
also
appli
optimis
dri
process
scaffold
monitor
qualiti
scaffold
industrialis
process
method
provid
refer
solvent
quantit
determin
porou
scaffold
materi
steroidassoci
osteonecrosi
saon
one
difficult
diseas
treat
larg
occur
larg
joint
lead
articular
surfac
collaps
expens
joint
replac
prognosi
joint
replac
saon
patient
poor
due
osteolysi
impair
osteogenesi
accordingli
research
develop
osteopromot
scaffold
readi
implant
would
capabl
activ
host
cell
differenti
angiogen
osteogen
lineag
would
desir
lowtemperatur
deposit
manufactur
ldm
uniqu
rapid
prototyp
technolog
provid
accur
pointtopoint
control
liquid
mould
materi
form
scaffold
gradient
pore
structur
studi
seri
porou
poli
lacticcoglycol
acid
tricalcium
phosphat
plgatcp
scaffold
fabric
use
ldm
techniqu
plgatcp
scaffold
exhibit
osteoconduct
activ
could
also
use
drug
carrier
process
scaffold
fabric
optimis
necessari
solvent
use
dissolv
plga
due
low
melt
point
liposolubl
highli
volatil
natur
howev
two
oxygen
atom
shown
carcinogen
anim
human
furthermor
may
also
toxic
liver
lung
kidney
central
nervou
system
defin
class
solvent
associ
less
sever
toxic
limit
ppm
accord
intern
regul
chines
pharmacopoeia
intern
confer
harmon
technic
requir
registr
pharmaceut
human
use
unit
state
pharmacopoeia
therefor
mandatori
test
residu
plgatcp
scaffold
test
also
necessari
registr
qualiti
control
novel
scaffold
date
establish
test
method
use
quantif
analysi
liquid
liquidlik
sampl
drink
water
wast
water
vaccin
cosmet
sampl
usual
process
doubl
distil
water
scaffold
pretreat
necessari
step
select
proper
solvent
analysi
report
determin
reliabl
water
variou
techniqu
includ
direct
aqueou
inject
purg
trap
ga
chromatographymass
spectrometr
gcm
gcm
analysi
continu
liquideliquid
extract
extract
convent
purg
trap
gcm
strictli
limit
poor
purg
effici
whose
detect
limit
time
higher
effici
purg
volatil
organ
compound
headspac
gcm
hsgcm
use
commonli
determin
poorli
purg
organ
solvent
cosmet
could
reach
target
compound
elimin
background
interfer
special
boil
point
volatil
organ
compound
therefor
hsgcm
chosen
analysi
method
scaffold
simplifi
pretreat
process
acquir
high
quantiti
chromatogram
spectrum
purpos
investig
develop
select
rapid
yet
simpl
robust
method
determin
plgatcp
porou
scaffold
hsgcm
procedur
includ
pretreat
scaffold
sampl
enrich
headspac
apparatu
separ
compon
gc
identif
ms
method
valid
appli
optimis
dri
process
scaffold
fabric
could
also
generalis
standard
andor
guidelin
wide
applic
standard
reagent
gc
grade
dimethyl
sulphoxid
gc
grade
obtain
aladdin
shanghai
china
dimethyl
formamid
dmf
hplc
grade
obtain
j
k
scientif
corpor
beij
china
plga
ratio
lactic
acid
glycol
acid
molecular
weight
da
provid
shandong
institut
medic
instrument
shandong
china
tcp
low
temperaturebtricalcium
phosphat
rang
particl
size
mm
obtain
chemic
precipit
purchas
shanghai
biolu
biomateri
co
ltd
shanghai
china
porou
scaffold
plgatcp
made
threedimension
print
base
ldm
techniqu
figur
sampl
fabric
plga
dissolv
ratio
weightvolum
tcp
mix
solut
ratio
weight
weight
tcp
plga
homogen
slurri
control
deposit
specif
posit
accord
model
predesign
comput
anim
design
fabric
temperatur
refriger
c
subsequ
scaffold
lyophilis
remov
solvent
fabric
matrix
blank
scaffold
fabric
follow
process
sampl
except
plga
dissolv
dimethylsulphoxid
instead
surfac
morpholog
prepar
scaffold
section
observ
scan
electron
microscopi
sem
jeol
tokyo
japan
kv
one
scaffold
weigh
g
lyophilis
c
pa
day
cut
five
g
scaffold
separ
dri
room
temperatur
day
day
day
day
day
vacuum
dri
oven
pressur
pa
select
best
freezedri
process
standard
solut
dmf
use
calibr
curv
ml
ml
ml
ml
standard
stock
solut
ppm
transfer
five
ml
volumetr
flask
dmf
separ
dilut
dmf
volum
mix
subsequ
ml
ppm
standard
solut
transfer
ml
volumetr
flask
dilut
dmf
volum
mix
obtain
ppm
standard
solut
standard
solut
na
co
solut
use
calibr
curv
ml
ml
ml
ml
ml
standard
stock
solut
ppm
transfer
five
ml
volumetr
flask
na
co
separ
dilut
na
co
solut
gml
volum
mix
standard
solut
includ
matrix
blank
scaffold
g
matrix
blank
scaffold
cut
piec
cm
transfer
headspac
vial
five
parallel
prepar
ml
five
differ
concentr
standard
solut
dmf
na
co
solut
use
calibr
curv
transfer
five
headspac
vial
one
one
standard
solut
describ
ml
transfer
vial
vial
close
immedi
heat
vial
minut
c
hsgcm
ga
sampl
vial
perform
optimis
solut
quantit
g
sampl
weigh
accur
cut
piec
cm
headspac
vial
dmf
ml
transfer
vial
vial
close
immedi
heat
vial
minut
c
hsgcm
ga
sampl
vial
perform
select
ion
mass
mode
sampl
quantifi
extern
standard
method
calibr
curv
determin
begin
sampl
set
day
blank
check
standard
run
sampl
set
overal
blank
check
standard
compris
minimum
total
sampl
analys
given
analysi
sequenc
ensur
stabil
method
hsgc
tandem
ms
use
identifi
quantifi
agil
california
usa
gc
use
separ
gc
equip
mm
mm
ms
column
california
usa
gc
coupl
agil
headspac
inject
agil
mass
spectromet
ms
oper
electr
ionis
mode
use
select
ion
monitor
mode
optimis
paramet
gcm
follow
tabl
specif
specif
describ
abil
analyt
method
separ
analyst
interest
accur
compon
expect
present
sampl
guid
principl
entitl
valid
guidelin
drug
qualiti
standard
analyt
method
provid
identif
requir
criteria
specif
test
blank
sampl
ppm
standard
solut
prepar
follow
prepar
protocol
detect
accord
chines
pharmacopoeia
edit
guidelin
accuraci
evalu
spike
recoveri
experi
matrix
blank
use
evalu
recoveri
describ
guidelin
sampl
prepar
process
g
scaffold
dissolv
ml
dmf
accord
chines
pharmacopoeia
intern
confer
harmon
technic
requir
registr
pharmaceut
human
use
unit
state
pharmacopoeia
product
ppm
convert
concentr
g
scaffold
ie
ppm
concentr
ml
dmf
accord
follow
formula
ppm
weight
scaffold
g
weight
dmf
z
ppm
volum
densiti
dmfz
ppm
ml
gl
z
ppm
mean
concentr
g
scaffold
ml
dmf
less
ppm
ppm
ppm
ppm
standard
solut
prepar
matrix
blank
scaffold
dmf
triplic
sampl
concentr
prepar
recoveri
calcul
follow
actual
concentr
theoret
concentr
method
precis
determin
use
standard
prepar
method
repeat
express
precis
analyt
method
includ
system
precis
sampl
prepar
describ
oper
condit
two
standard
ppm
process
two
differ
research
assist
day
determin
intraand
interday
precis
use
method
everi
sampl
analyz
six
time
rel
standard
deviat
rsd
use
evalu
precis
limit
detect
lod
lowest
amount
detect
necessarili
quantifi
accord
guidelin
defin
concentr
requir
give
signal
nois
ratio
sn
limit
quantif
loq
lowest
amount
quantifi
accur
defin
concentr
requir
give
signal
nois
ratio
sn
nois
ratio
calcul
automat
mass
select
detector
msd
chemstat
agil
target
peak
integr
serial
sampl
low
concentr
ppb
ppb
ppb
ppb
detect
analys
seri
concentr
standard
ppm
prepar
per
prepar
protocol
describ
earlier
calibr
curv
construct
analyst
plot
peak
area
quantifi
ion
versu
concentr
ppm
slope
intercept
correl
coeffici
calcul
use
linear
regress
analysi
robust
method
robust
describ
abil
reproduc
analyt
method
differ
circumst
small
chang
exist
robust
test
set
evalu
robust
method
special
factor
chang
gcm
detect
column
differ
brand
batch
number
differ
solid
phase
differ
type
support
flow
rate
carrier
ga
temperatur
column
inlet
detect
valid
use
two
differ
column
detect
sampl
evalu
robust
column
detect
sampl
triplic
scaffold
dri
c
day
day
day
day
day
vacuum
dri
oven
quantifi
optimis
condit
content
compar
differ
scaffold
process
differ
dri
procedur
peak
area
differ
extract
present
mean
ae
standard
deviat
three
repeat
experi
test
perform
use
spss
softwar
chicago
il
usa
comparison
statist
signific
p
photo
print
porou
scaffold
shown
figur
sem
imag
found
scaffold
well
interconnect
macropor
structur
figur
numer
micropor
observ
wall
surfac
scaffold
framework
pore
size
rang
mm
mm
figur
dmf
optim
solvent
dissolv
scaffold
gcm
investig
two
solvent
doubl
distil
h
dmf
two
sodium
solut
nacl
solut
na
co
solut
chosen
optimis
solvent
sampl
prepar
figur
order
peak
area
doubl
distil
na
co
eh
nacleh
h
dmf
p
vs
h
n
z
figur
howev
area
concentr
calibr
curv
without
matrix
twice
matrix
dissolv
na
co
eh
differ
found
calibr
curv
without
matrix
blank
scaffold
dissolv
dmf
retent
time
target
mass
min
chromatograph
resolut
peak
resolut
rs
figur
tail
factor
target
peak
number
theoret
plate
result
show
method
specif
peak
interfer
peak
interest
retent
time
signific
differ
observ
standard
compon
figur
accuraci
precis
robust
linear
method
summaris
tabl
recoveri
experi
gave
recoveri
tabl
repeat
method
express
rsd
five
continu
standard
rsd
peak
area
rsd
retent
time
peak
area
describ
intraday
precis
respect
n
z
interday
precis
calcul
describ
intermedi
precis
retent
time
peak
area
n
z
respect
tabl
linear
rang
determin
ppm
calibr
curv
linear
standard
compon
correl
coeffici
lod
lqd
ppb
ppb
respect
result
show
resolut
tail
factor
number
theoret
plate
column
chang
met
system
suitabl
requir
rsd
six
sampl
tabl
impli
area
target
peak
littl
chang
result
met
requir
guidelin
describ
chines
pharmacopoeia
edit
tabl
establish
method
use
monitor
dri
process
control
qualiti
scaffold
result
show
scaffold
lyophilis
c
pa
day
dri
vacuum
c
pa
day
ppm
extens
freez
dri
time
day
reduc
content
figur
accord
data
scaffold
freezedri
day
dri
vacuum
day
control
content
satisfi
safeti
limit
threedimension
print
porou
scaffold
promis
regen
strategi
bone
defect
repair
orthopaed
newli
develop
medic
product
safeti
issu
consid
import
one
class
solvent
less
sever
toxic
content
residu
novel
print
plgatcp
scaffold
rigor
control
first
develop
hsgcm
method
test
plgatcp
porou
scaffold
method
utilis
reproduc
highli
recoveri
sampl
prepar
process
effici
separ
technolog
specif
singleion
monitor
mass
detect
quantifi
plgatcp
porou
scaffold
differ
liquid
liquidlik
sampl
extract
solid
scaffold
first
step
four
solut
use
result
detect
amount
exactli
invers
relat
solubl
differ
solut
na
co
solut
show
highest
sensit
due
saltingout
effect
howev
first
method
test
ga
solid
porou
structur
investig
matrix
effect
differ
solut
two
differ
extract
system
one
na
co
solut
retain
porou
structur
scaffold
dmf
solut
without
porou
structur
dmf
solut
scaffold
dissolv
powder
distribut
solut
phase
ga
phase
detect
amount
determin
solubl
dmf
detect
amount
dmf
without
matrix
blank
scaffold
na
co
solut
matrix
blank
scaffold
distribut
three
phase
scaffold
solut
ga
detect
amount
determin
solubl
na
co
also
attach
porou
scaffold
thu
detect
amount
na
co
solut
na
co
solut
matrix
blank
scaffold
figur
fabric
porou
scaffold
regular
macropor
size
among
mm
mm
well
irregular
micropor
size
mm
mm
pore
figur
might
caus
matrix
effect
thu
select
dmf
extract
scaffold
pretreat
process
gcm
method
follow
method
valid
result
confirm
feasibl
procedur
method
valid
good
accuraci
reproduc
met
methodolog
requir
guidelin
describ
chines
pharmacopoeia
edit
one
indispens
file
medic
devic
approv
registr
use
establish
method
monitor
dri
process
scaffold
guarante
residu
less
ppm
accord
chines
pharmacopoeia
result
show
scaffold
lyophilis
c
pa
day
dri
vacuum
c
pa
day
ppm
figur
examin
threephas
diagram
found
condit
c
pa
lyophilis
effici
remov
figur
environ
prefer
solid
rather
ga
therefor
optimis
dri
process
lower
pressur
increas
temperatur
improv
freezedri
effici
newli
establish
quantit
method
also
use
verifi
hypothesi
optimis
freezedri
process
scaffold
lyophilis
day
dri
c
day
day
day
day
day
vacuum
dri
oven
ppm
z
part
per
million
fact
use
establish
method
test
plga
raw
materi
differ
supplier
detect
chloroform
batch
figur
howev
want
accur
quantifi
chloroform
dichloromethan
pretreat
extract
process
commonli
use
paramet
gcm
specif
tune
target
solvent
meet
requir
method
valid
investig
hsgcm
method
firstli
develop
test
plgatcp
porou
scaffold
method
valid
meet
requir
chines
pharmacopoeia
edit
provid
residu
test
method
plgatcp
scaffold
cfda
registr
first
resolv
method
pretreat
solid
scaffold
elimin
matrix
effect
develop
process
analysi
method
use
optimis
process
dri
scaffold
satisfi
product
requir
addit
import
tool
qualiti
control
composit
scaffold
threedimension
print
porou
scaffold
promis
regen
strategi
bone
defect
repair
orthopaed
newli
develop
medic
product
safeti
issu
consid
import
one
class
solvent
less
sever
toxic
content
residu
novel
print
plgatcp
scaffold
rigor
control
accord
intern
regul
chines
pharmacopoeia
intern
confer
harmon
technic
requir
registr
pharmaceut
human
use
unit
state
pharmacopoeia
work
firstli
develop
hsgcm
method
test
plgatcp
porou
scaffold
import
file
medic
devic
approv
registr
appli
enterpris
standard
optimis
dri
process
scaffold
monitor
qualiti
scaffold
industrialis
process
author
declar
conflict
interest
work
